Breast cancers are classified into subtypes based on the hormone-receptor positivity, human epidermal growth factor receptor type 2 (HER2) status, and proliferative activity of the tumor cells, and they are staged according to the size and local invasiveness of the tumor and the nodal and distant metastasis statuses [2]. The gene discussed is NR4A1; the disease is neoplasm.